Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility

Detalhes bibliográficos
Autor(a) principal: Oliveira, Maria João Carvalho Meneses
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/5890
Resumo: Diabetes mellitus (DM) is a pandemic metabolic disease that affects an enormous amount of males at a very early age. It is a leading cause of morbidity and mortality, in both developed and in developing countries. Type 2 diabetes mellitus (T2DM) is responsible for the vast majority of DM cases. It comprises individuals who present insulin resistance and relative insulin deficiency. Unlike type 1 diabetes mellitus (T1DM), the main triggering factor of T2DM seems to be the new lifestyle of modern societies rather than genetic factors. The process of production of viable spermatozoa is strictly regulated and dependent of several factors. Any alterations in this process may result in fertility problems in the male. The developing germ cells are dependent on the metabolic cooperation established with the Sertoli cells (SCs), being reliant on the lactate produced by these testicular somatic cells, as energy source. Of the various antidiabetics available in the market, a number of them have a direct action in the individual metabolic homeodynamics. However, its mechanisms of action are different and vary dependent on several factors (e.g. tissue or target cells). In this work, we evaluated the effect of two antidiabetic drugs, pioglitazone and metformin, in human Sertoli cell metabolism (hSCs). Our results suggest that, like metformin, pioglitazone may be a suitable antidiabetic drug for young men and those in reproductive age. These novel findings suggest a possible protective role of pioglitazone to male reproductive function.
id RCAP_dbf29dbcb6ed543c2c253d7937531624
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/5890
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male FertilityEfeito de Antidiabéticos em Células de Sertoli Humanas: Implicações Para a FertilidadeCélulas de SertoliEspermatogéneseInfertilidadeMetforminaMitocôndriaPioglitazonaDomínio/Área Científica::Ciências Médicas::Ciências BiomédicasDiabetes mellitus (DM) is a pandemic metabolic disease that affects an enormous amount of males at a very early age. It is a leading cause of morbidity and mortality, in both developed and in developing countries. Type 2 diabetes mellitus (T2DM) is responsible for the vast majority of DM cases. It comprises individuals who present insulin resistance and relative insulin deficiency. Unlike type 1 diabetes mellitus (T1DM), the main triggering factor of T2DM seems to be the new lifestyle of modern societies rather than genetic factors. The process of production of viable spermatozoa is strictly regulated and dependent of several factors. Any alterations in this process may result in fertility problems in the male. The developing germ cells are dependent on the metabolic cooperation established with the Sertoli cells (SCs), being reliant on the lactate produced by these testicular somatic cells, as energy source. Of the various antidiabetics available in the market, a number of them have a direct action in the individual metabolic homeodynamics. However, its mechanisms of action are different and vary dependent on several factors (e.g. tissue or target cells). In this work, we evaluated the effect of two antidiabetic drugs, pioglitazone and metformin, in human Sertoli cell metabolism (hSCs). Our results suggest that, like metformin, pioglitazone may be a suitable antidiabetic drug for young men and those in reproductive age. These novel findings suggest a possible protective role of pioglitazone to male reproductive function.A diabetes mellitus (DM) é uma doença metabólica que está a atingir proporções pandémicas, afetando um elevado número de homens numa idade muito jovem. É uma das principais causas de morbilidade e mortalidade em países desenvolvidos e em desenvolvimento. A diabetes mellitus tipo 2 (T2DM) é responsável pela grande maioria de casos de DM. Compreende indivíduos que apresentam resistência à insulina e uma relativa deficiência na secreção de insulina. Ao contrário da diabetes mellitus tipo 1 (T1DM), o principal fator para o desenvolvimento da doença parece ser o estilo de vida das sociedades modernas em vez de fatores genéticos. O processo de produção de espermatozóides viáveis é altamente regulado, dependente de diversos fatores, e qualquer alteração pode resultar em problemas de fertilidade no homem. Entre outros aspectos, as células germinativas são dependentes da cooperação metabólica que estabelecem com as células de Sertoli (SCs), que mostrou ser essencial para a ocorrência da espermatogénese. Dos diferentes antidiabéticos disponíveis no mercado, vários têm uma ação na homeodinâmica metabólica do indivíduo. Contudo, os seus mecanismos de ação são distintos e variam dependendo de diversos fatores (p. ex. tecido ou células alvo). Neste trabalho, avaliámos o efeito de dois antidiabéticos, a pioglitazona e a metformina, no metabolismo de células de Sertoli humanas (hSCs). Os nossos resultados sugerem que, tal como a metformina, a pioglitazona é um antidiabético adequado para homens em idade reprodutiva. Para além disso, os resultados obtidos neste trabalho levam-nos a sugerir um possível papel protetor da pioglitazona na função reprodutiva masculina.Alves, Marco Aurélio GouveiaOliveira, Pedro FontesAlves, Marco Aurélio GouveiauBibliorumOliveira, Maria João Carvalho Meneses2018-08-30T15:34:17Z2015-6-52015-07-022015-07-02T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/5890TID:201644924enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:44:05Zoai:ubibliorum.ubi.pt:10400.6/5890Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:46:44.399322Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
Efeito de Antidiabéticos em Células de Sertoli Humanas: Implicações Para a Fertilidade
title Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
spellingShingle Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
Oliveira, Maria João Carvalho Meneses
Células de Sertoli
Espermatogénese
Infertilidade
Metformina
Mitocôndria
Pioglitazona
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
title_short Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
title_full Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
title_fullStr Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
title_full_unstemmed Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
title_sort Effect of Antidiabetic Drugs in Human Sertoli Cells: Implications for Male Fertility
author Oliveira, Maria João Carvalho Meneses
author_facet Oliveira, Maria João Carvalho Meneses
author_role author
dc.contributor.none.fl_str_mv Alves, Marco Aurélio Gouveia
Oliveira, Pedro Fontes
Alves, Marco Aurélio Gouveia
uBibliorum
dc.contributor.author.fl_str_mv Oliveira, Maria João Carvalho Meneses
dc.subject.por.fl_str_mv Células de Sertoli
Espermatogénese
Infertilidade
Metformina
Mitocôndria
Pioglitazona
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
topic Células de Sertoli
Espermatogénese
Infertilidade
Metformina
Mitocôndria
Pioglitazona
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
description Diabetes mellitus (DM) is a pandemic metabolic disease that affects an enormous amount of males at a very early age. It is a leading cause of morbidity and mortality, in both developed and in developing countries. Type 2 diabetes mellitus (T2DM) is responsible for the vast majority of DM cases. It comprises individuals who present insulin resistance and relative insulin deficiency. Unlike type 1 diabetes mellitus (T1DM), the main triggering factor of T2DM seems to be the new lifestyle of modern societies rather than genetic factors. The process of production of viable spermatozoa is strictly regulated and dependent of several factors. Any alterations in this process may result in fertility problems in the male. The developing germ cells are dependent on the metabolic cooperation established with the Sertoli cells (SCs), being reliant on the lactate produced by these testicular somatic cells, as energy source. Of the various antidiabetics available in the market, a number of them have a direct action in the individual metabolic homeodynamics. However, its mechanisms of action are different and vary dependent on several factors (e.g. tissue or target cells). In this work, we evaluated the effect of two antidiabetic drugs, pioglitazone and metformin, in human Sertoli cell metabolism (hSCs). Our results suggest that, like metformin, pioglitazone may be a suitable antidiabetic drug for young men and those in reproductive age. These novel findings suggest a possible protective role of pioglitazone to male reproductive function.
publishDate 2015
dc.date.none.fl_str_mv 2015-6-5
2015-07-02
2015-07-02T00:00:00Z
2018-08-30T15:34:17Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/5890
TID:201644924
url http://hdl.handle.net/10400.6/5890
identifier_str_mv TID:201644924
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136363290820608